Multiple Sclerosis Health Center
Having multiple sclerosis (MS) today is a lot different than it was a few decades ago. Medications like interferon beta, glatiramer acetate (Copaxone), and others have literally changed the course of this disease – for the better. "Literally with the interferons, hundreds of thousands of patients around the world have taken these drugs successfully," says Aaron Miller, MD, Professor of Neurology at the Icahn School of Medicine at Mount Sinai, and Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at the Mount Sinai Health System.
-Dr. Aaron Miller, Professor, Neurology, Icahn School of Medicine at Mount Sinai, Medical Director, Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Health System
New Study Details The Various Ways Patients with Multiple Sclerosis Develop Impairment
Feb 22, 2022 View All Press Releases
Two Mount Sinai Experts Receive Honors From the National Multiple Sclerosis Society
Sep 16, 2021 View All Press Releases